{
  "id": 106681,
  "title": "Pathos does deals with AstraZeneca, China's Alphamab, seeks up to $300M Series E",
  "url": "https://urgent.news/2026/08/04/pathos-does-deals-with-astrazeneca-chinas-alphamab-seeks-up-to-300m",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-08-04T00:00:51.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/pathos-does-deals-with-astrazeneca-chinas-alphamab-seeks-up-to-300m-series-e/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pathos AI is firing on all cylinders. The technology and drug development company told Endpoints News that it signed a major antibody-drug conjugate (ADC) deal with a Chinese biotech and teamed up with its CEO's ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}